These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 26289723

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits.
    Frederix I, Solmi F, Piepoli MF, Dendale P.
    Eur J Prev Cardiol; 2017 Nov; 24(16):1708-1717. PubMed ID: 28925749
    [Abstract] [Full Text] [Related]

  • 3. Cost-Utility Analysis of a Cardiac Telerehabilitation Program: The Teledialog Project.
    Kidholm K, Rasmussen MK, Andreasen JJ, Hansen J, Nielsen G, Spindler H, Dinesen B.
    Telemed J E Health; 2016 Jul; 22(7):553-63. PubMed ID: 26713491
    [Abstract] [Full Text] [Related]

  • 4. Effects of cardiac telerehabilitation in patients with coronary artery disease using a personalised patient-centred web application: protocol for the SmartCare-CAD randomised controlled trial.
    Brouwers RW, Kraal JJ, Traa SC, Spee RF, Oostveen LM, Kemps HM.
    BMC Cardiovasc Disord; 2017 Jan 31; 17(1):46. PubMed ID: 28143388
    [Abstract] [Full Text] [Related]

  • 5. Cost-Utility Analysis of Home-Based Telerehabilitation Compared With Centre-Based Rehabilitation in Patients With Heart Failure.
    Hwang R, Morris NR, Mandrusiak A, Bruning J, Peters R, Korczyk D, Russell T.
    Heart Lung Circ; 2019 Dec 31; 28(12):1795-1803. PubMed ID: 30528811
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands.
    Brouwers RWM, van der Poort EKJ, Kemps HMC, van den Akker-van Marle ME, Kraal JJ.
    JAMA Netw Open; 2021 Dec 01; 4(12):e2136652. PubMed ID: 34854907
    [Abstract] [Full Text] [Related]

  • 7. Economic and social impact of increased cardiac rehabilitation uptake and cardiac telerehabilitation in Belgium - a cost-benefit analysis.
    Frederix I, Vandijck D, Hens N, De Sutter J, Dendale P.
    Acta Cardiol; 2018 Jun 01; 73(3):222-229. PubMed ID: 28799460
    [Abstract] [Full Text] [Related]

  • 8. EU-CaRE study: Could exercise-based cardiac telerehabilitation also be cost-effective in elderly?
    Scherrenberg M, Zeymer U, Schneider S, Van der Velde AE, Wilhelm M, Van't Hof AWJ, Kolkman E, Prins LF, Prescott E, Iliou MC, Peña-Gil C, Ardissino D, De Kluiver EP, Dendale P.
    Int J Cardiol; 2021 Oct 01; 340():1-6. PubMed ID: 34419529
    [Abstract] [Full Text] [Related]

  • 9. "As du Coeur" study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease.
    Bailly L, Mossé P, Diagana S, Fournier M, d'Arripe-Longueville F, Diagana O, Gal J, Grebet J, Moncada M, Domerego JJ, Radel R, Fabre R, Fuch A, Pradier C.
    BMC Cardiovasc Disord; 2018 Dec 06; 18(1):225. PubMed ID: 30522438
    [Abstract] [Full Text] [Related]

  • 10. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N, Furlong W, Perkins A, Feeny D, Torrance GW.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 06; 15(5):608-15. PubMed ID: 18800005
    [Abstract] [Full Text] [Related]

  • 11. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial.
    Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, Van Craenenbroeck E, Van Driessche N, Dendale P.
    J Med Internet Res; 2015 Jul 23; 17(7):e185. PubMed ID: 26206311
    [Abstract] [Full Text] [Related]

  • 12. Economic evaluation of exercise-based cardiac rehabilitation in patients with a recent acute coronary syndrome.
    Hautala AJ, Kiviniemi AM, Mäkikallio T, Koistinen P, Ryynänen OP, Martikainen JA, Seppänen T, Huikuri HV, Tulppo MP.
    Scand J Med Sci Sports; 2017 Nov 23; 27(11):1395-1403. PubMed ID: 27541076
    [Abstract] [Full Text] [Related]

  • 13. Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
    Mittmann N, Au HJ, Tu D, O'Callaghan CJ, Isogai PK, Karapetis CS, Zalcberg JR, Evans WK, Moore MJ, Siddiqui J, Findlay B, Colwell B, Simes J, Gibbs P, Links M, Tebbutt NC, Jonker DJ, Working Group on Economic Analysis of National Cancer Institute of Canada Clinical Trials Group, Australasian Gastrointestinal Interest Group.
    J Natl Cancer Inst; 2009 Sep 02; 101(17):1182-92. PubMed ID: 19666851
    [Abstract] [Full Text] [Related]

  • 14. PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform.
    Claes J, Buys R, Woods C, Briggs A, Geue C, Aitken M, Moyna N, Moran K, McCaffrey N, Chouvarda I, Walsh D, Budts W, Filos D, Triantafyllidis A, Maglaveras N, Cornelissen VA.
    BMJ Open; 2017 Jun 30; 7(6):e016781. PubMed ID: 28667228
    [Abstract] [Full Text] [Related]

  • 15. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
    Taylor RS, Sadler S, Dalal HM, Warren FC, Jolly K, Davis RC, Doherty P, Miles J, Greaves C, Wingham J, Hillsdon M, Abraham C, Frost J, Singh S, Hayward C, Eyre V, Paul K, Lang CC, Smith K.
    Eur J Prev Cardiol; 2019 Aug 30; 26(12):1252-1261. PubMed ID: 30884975
    [Abstract] [Full Text] [Related]

  • 16. Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study.
    Kraal JJ, Van den Akker-Van Marle ME, Abu-Hanna A, Stut W, Peek N, Kemps HM.
    Eur J Prev Cardiol; 2017 Aug 30; 24(12):1260-1273. PubMed ID: 28534417
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of telerehabilitation versus traditional care after total hip replacement: A trial-based economic evaluation.
    Nelson M, Russell T, Crossley K, Bourke M, McPhail S.
    J Telemed Telecare; 2021 Jul 30; 27(6):359-366. PubMed ID: 31530065
    [Abstract] [Full Text] [Related]

  • 18. Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Chew DS, Li Y, Zeitouni M, Whellan DJ, Kitzman D, Mentz RJ, Duncan P, Pastva AM, Reeves GR, Nelson MB, Chen H, Reed SD.
    JAMA Cardiol; 2022 Feb 01; 7(2):140-148. PubMed ID: 34817542
    [Abstract] [Full Text] [Related]

  • 19. Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis.
    Senanayake S, Halahakone U, Abell B, Kularatna S, McCreanor V, McPhail SM, Redfern J, Tom Briffa, Parsonage W.
    BMC Health Serv Res; 2023 May 20; 23(1):512. PubMed ID: 37208666
    [Abstract] [Full Text] [Related]

  • 20. Telerehab III: a multi-center randomized, controlled trial investigating the long-term effectiveness of a comprehensive cardiac telerehabilitation program--rationale and study design.
    Frederix I, Hansen D, Coninx K, Vandervoort P, Van Craenenbroeck EM, Vrints C, Dendale P.
    BMC Cardiovasc Disord; 2015 May 07; 15():29. PubMed ID: 25948479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.